Diosmetin reduces bone loss and osteoclastogenesis by regulating the expression of TRPV1 in osteoporosis rats

BACKGROUND: Osteoporosis is a systemic skeletal disorder and occurs frequently in postmenopausal women and older men. This study aimed to examine whether diosmetin (DIO) can relieve estrogen deficiency—induced osteoporosis and to explore the underlying mechanisms of this potential effect. METHODS: F...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Song, Huang, Youyi, Chen, Yong, Zhou, Renyi, Yang, Xiaozhong, Zou, Yi, Gao, Daxin, Huang, Hua, Yu, Dongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661890/
https://www.ncbi.nlm.nih.gov/pubmed/33209892
http://dx.doi.org/10.21037/atm-20-6309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661890/
https://www.ncbi.nlm.nih.gov/pubmed/33209892
http://dx.doi.org/10.21037/atm-20-6309

Ejemplares similares